 SAN FRANCISCO, Oct. 5, 2021 PRNewswire -- Hagens Berman urges Owlet, Inc. NYSE: OWLT investors with significant losses to submit your losses now. Visit: Contact An Attorney Now: 844-916-0895 Owlet, Inc. OWLT Investigation: The firms investigation focuses on Owlets claims about its in-home pediatric monitoring and analytics technologies which are intended to detect infant ailments such as respiratory syncytial virus and supraventricular tachycardia and, thereby, decrease infant death due to Sudden Unexplained Infant Death and Sudden Infant Death Syndrome. 